(Reuters) - Questcor Pharmaceuticals Inc said it is now eligible to provide lower Medicaid rebates on its flagship multiple sclerosis drug, Acthar Gel, allowing for improved financial results in the future. The company said the government informed it that Acthar is now eligible for lower rebates for patients under Medicaid -- the program that funds medical and health-related services for the poor and disabled. In a filing, Questcor said it estimates the rebate rate to be cut from about 100 percent of the amount it charges its distributor to 23. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment